首页> 美国卫生研究院文献>Journal of Translational Medicine >Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
【2h】

Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin

机译:绘制癌症药物开发中的知识转化和创新过程图:阿霉素脂质体案例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We explored how the knowledge translation and innovation processes are structured when theyresult in innovations, as in the case of liposomal doxorubicin research. In order to map the processes, a literature network analysis was made through Cytoscape and semantic analysis was performed by GOPubmed which is based in the controlled vocabularies MeSH (Medical Subject Headings) and GO (Gene Ontology). We found clusters related to different stages of the technological development (invention, innovation and imitation) and the knowledge translation process (preclinical, translational and clinical research), and we were able to map the historic emergence of Doxil as a paradigmatic nanodrug. This research could be a powerful methodological tool for decision-making and innovation management in drug delivery research.
机译:我们探索了知识转化和创新过程在导致创新时的结构,例如脂质体阿霉素研究的情况。为了映射过程,通过Cytoscape进行了文献网络分析,并由GOPubmed进行了语义分析,GOPubmed基于受控词汇MeSH(医学主题词)和GO(基因本体论)。我们发现了与技术发展的不同阶段(发明,创新和模仿)和知识转化过程(临床前,转化和临床研究)相关的集群,并且我们能够描绘出Doxil作为范例性纳米药物的历史性兴起。这项研究可能是药物交付研究中决策和创新管理的有力方法论工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号